当前位置：药药网 / 药品 / 美国NDC未完成药物数据库文件(本栏目更新到2026-3-31)
药品名称： 商品名称： 药品NDC： 上市日期： -格式:2020-5-3
注册申请号： 市场分类： 活性成分： 持证企业：
 美国NDC未完成药物数据库文件21130条(本栏目更新到2026-3-31)
药品名称(分析)
商品名
药品NDC
专利人(分析)
上市日期
活性成分
市场分类
规格(分析)
申请号
Insulin human
DRUG FOR FURTHER PROCESSING
0002-0013
Eli Lilly and Company
19830627
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
100
0002-0013_15810e26-b479-41b8-9d13-9dc503a71a2a
Insulin human
DRUG FOR FURTHER PROCESSING
0002-0095
Eli Lilly and Company
20151229
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
500
0002-0095_15810e26-b479-41b8-9d13-9dc503a71a2a
Insulin human
DRUG FOR FURTHER PROCESSING
0002-0096
Eli Lilly and Company
19940331
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
500
0002-0096_15810e26-b479-41b8-9d13-9dc503a71a2a
Insulin human
DRUG FOR FURTHER PROCESSING
0002-0113
Eli Lilly and Company
19830627
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
100
0002-0113_55aa4078-e1e8-4338-b2b5-a9298b3c16e2
Insulin human
DRUG FOR FURTHER PROCESSING
0002-0119
Eli Lilly and Company
20131107
INSULIN HUMAN
DRUG FOR FURTHER PROCESSING
100
0002-0119_55aa4078-e1e8-4338-b2b5-a9298b3c16e2
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-0121
Eli Lilly and Company
20070906
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-0121_45c92a9b-de19-4856-ab64-ff84060d5af5
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-0124
Eli Lilly and Company
19991222
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-0124_43f0bbe7-2a71-489a-82ed-f60435488eea
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-0137
Eli Lilly and Company
20070906
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-0137_43f0bbe7-2a71-489a-82ed-f60435488eea
Insulin human
BULK INGREDIENT
0002-0485
Eli Lilly and Company
20150401
INSULIN HUMAN
BULK INGREDIENT
1
0002-0485_492f6cbf-92d2-43fd-829a-a1e283330288
Insulin lispro
BULK INGREDIENT
0002-0535
Eli Lilly and Company
20140131
INSULIN LISPRO
BULK INGREDIENT
1
0002-0535_ba6cf5d1-45c2-4452-a56b-c80f45785785
tirzepatide
BULK INGREDIENT
0002-0770
Eli Lilly and Company
20230620
TIRZEPATIDE
BULK INGREDIENT
1
0002-0770_09336bb8-1a74-4fdb-8f99-febe7fc2f864
diluent
DRUG FOR FURTHER PROCESSING
0002-0800
Eli Lilly and Company
19870710
WATER
DRUG FOR FURTHER PROCESSING
1
0002-0800_55aa4078-e1e8-4338-b2b5-a9298b3c16e2
Insulin lispro-aabc
DRUG FOR FURTHER PROCESSING
0002-0872
Eli Lilly and Company
20200615
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-0872_83fc33d1-b5d7-494c-bcc7-f1d5f511220d
Insulin glargine
DRUG FOR FURTHER PROCESSING
0002-1076
Eli Lilly and Company
20151216
INSULIN GLARGINE
DRUG FOR FURTHER PROCESSING
100
0002-1076_e2a4f848-408f-442b-b4bc-8fc5d422fcfa
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-1099
Eli Lilly and Company
20150526
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
200
0002-1099_0f2caf15-19e5-4e09-ad0d-265df1caa6b0
Dulaglutide
DRUG FOR FURTHER PROCESSING
0002-1401
Eli Lilly and Company
20140922
DULAGLUTIDE
DRUG FOR FURTHER PROCESSING
.75
0002-1401_f871e830-b3d5-4d94-9c15-0af014307913
Dulaglutide
DRUG FOR FURTHER PROCESSING
0002-1402
Eli Lilly and Company
20140922
DULAGLUTIDE
DRUG FOR FURTHER PROCESSING
1.5
0002-1402_f871e830-b3d5-4d94-9c15-0af014307913
galcanezumab-gnlm
DRUG FOR FURTHER PROCESSING
0002-1436
Eli Lilly and Company
20180927
GALCANEZUMAB
DRUG FOR FURTHER PROCESSING
120
0002-1436_368df5d9-5eeb-49c7-a0dd-8a326ee5d78f
Insulin glargine
DRUG FOR FURTHER PROCESSING
0002-1437
Eli Lilly and Company
20151216
INSULIN GLARGINE
DRUG FOR FURTHER PROCESSING
100
0002-1437_e2a4f848-408f-442b-b4bc-8fc5d422fcfa
Insulin lispro
DRUG FOR FURTHER PROCESSING
0002-1455
Eli Lilly and Company
20170606
INSULIN LISPRO
DRUG FOR FURTHER PROCESSING
100
0002-1455_0f2caf15-19e5-4e09-ad0d-265df1caa6b0
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3